Published on Web 06/28/2008
Orthogonal Pd- and Cu-Based Catalyst Systems for C- and
N-Arylation of Oxindoles
Ryan A. Altman, Alan M. Hyde, Xiaohua Huang, and Stephen L. Buchwald*
Department of Chemistry, Massachusetts Institute of Technology,
Cambridge, Massachusetts 02139
Received May 2, 2008; E-mail: sbuchwal@mit.edu
Abstract: In the cross-coupling reactions of unprotected oxindoles with aryl halides, Pd- and Cu-based
catalyst systems displayed orthogonal chemoselectivity. A Pd-dialkylbiarylphosphine-based catalyst system
chemoselectively arylated oxindole at the 3 position, while arylation occurred exclusively at the nitrogen
using a Cu-diamine-based catalyst system. Computational examination of the relevant L1Pd(Ar)(oxindolate)
and diamine-Cu(oxindolate) species was performed to gain mechanistic insight into the controlling features
of the observed chemoselectivity.
Introduction
of the identical acidities of the protons in positions C3 and N1
(pKa ) 18.5),8 the cross-coupling reactions of oxindole with
In recent years, Pd-catalyzed1 and Cu-catalyzed2 nucleophilic
substitution reactions of aryl halides have been areas of intensive
research. Our laboratory has been intimately involved in
designing and developing highly efficient and user-friendly Pd-
and Cu-based catalyst systems to cross-couple aryl halides with
a wide variety of nucleophiles, including amides3,4 and ketone
enolate derivatives.5,6
Generally, Cu- and Pd-catalyzed arylation reactions of both
linear and cyclic aliphatic amides react at the more acidic N-H
moiety as opposed to the less acidic C-HR position. For
instance, when reacting 2-pyrrolidinone with aryl halides, both
Cu-diamine- and Pd-biarylmonophosphine-based catalyst sys-
tems provide the N-aryl amide in excellent yield (Scheme 1).3,4
Ongoing work in our and other laboratories7 has identified
oxindole as a unique substrate for chemoselective metal-
catalyzed cross-coupling reactions with aryl halides. Because
aryl halides might provide either the C-aryl or the N-aryl
products.
Importantly, N1-aryl and C3-aryl oxindole products of the
type generated from the reactions described in this manuscript
display interesting biological activities with therapeutic applica-
tions (Figure 1).9 In addition, the amide of the N-aryl oxindole
can be cleaved to provide access to a variety of derivatives of
2-(2-phenylamino)phenyl)ethanoic acid nonsteroidal anti-inflam-
matory agents, such as Lumiracoxib10 and Diclofenac.11
Herein, we describe improved reaction conditions for the Cu-
catalyzed N1-arylation reaction with aryl iodides and bromides
and general reaction conditions for the Pd-catalyzed C3-arylation
reaction of unprotected oxindoles with aryl chlorides and
tosylates. Further, we report computational studies that suggest
reasonable explanations for the observed selectivity.
Results
(1) (a) Culkin, D. A.; Hartwig, J. F. Acc. Chem. Res. 2003, 36, 234. (b)
Jiang, L.; Buchwald, S. L. Palladium-catalyzed aromatic carbon-
nitrogen bond formation. In Metal-Catalyzed Cross-Coupling Reac-
tions, 2nd ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH:
Weinheim, Germany, 2004; pp 699-760.
Pd-Catalyzed C3-Arylation of Oxindoles. The use of 1%
Pd2(dba)3 and 5% XPhos (Figure 2) was found to facilitate the
(2) (a) Monnier, F.; Taillefer, M. Angew. Chem., Int. Ed. 2008, 47, 3096.
(b) Beletskaya, I. P.; Cheprakov, A. V. Coord. Chem. ReV. 2004, 2337.
(c) Ley, S. V.; Thomas, A. W. Angew. Chem., Int. Ed. 2003, 42, 5400.
(d) Kunz, K.; Scholz, U.; Ganzer, D. Synlett 2003, 2428.
(3) For Cu-catalyzed N-arylation of amides using N,N′-dimethyl-1,2-
ethylenediamine-derived ligands, see:(a) Klapars, A.; Antilla, J. C.;
Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7727. (b)
Klapars, A.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2002,
124, 7421.
(7) (a) Phillips, D. P.; Hudson, A. R.; Nguyen, B.; Lau, T. L.; McNeill,
M. H.; Dalgard, J. E.; Chen, J. H.; Penuliar, R. J.; Miller, T. A.; Zhi,
L. Tetrahedron Lett. 2006, 47, 7137. (b) Huang, J.; Bunel, E.; Faul,
M. M. Org. Lett. 2007, 9, 4343. (c) Durbin, M. J.; Willis, M. C. Org.
Lett. 2008, 10, 1413. (d) van den Hoogenband, A.; Lange, J. H. M.;
Iwema-Bakker, W. I.;.; den Hartog, J. A. J.; van Schaik, J.; Feenstra,
R. W.; Terpstra, J. W. Tetrahedron Lett. 2006, 47, 4361.
(8) Bordwell, F. G.; Fried, H. E. J. Org. Chem. 1991, 56, 4218.
(9) (a) Luk, K. C.; So, S. S.; Zhang, J.; Zhang, Z. (F. Hoffman-LaRoche
AG) Oxindole Derivatives. WO 2006/136606 A3, December 28, 2006.
(b) Hewawasam, P.; Gribkoff, V. K.; Pendri, Y.; Dworetzky, S. I.;
Meanwell, N. A.; Martinez, E.; Boissard, C. G.; Post-Munson, D. J.;
Trojnacki, J. T.; Yeleswaram, K.; Pajor, L. M.; Knipe, J.; Gao, Q.;
Perrone, R.; Starrett, J. E., Jr. Bioorg. Med. Chem. Lett. 2002, 12,
1023. (c) Sarges, R.; Howard, H. R.; Koe, K.; Weissman, A. J. Med.
Chem. 1989, 32, 437.
(4) For Pd-catalyzed amidation of aryl halides using Xantphos and
dialkylbiarylmonophosphine ligands, see:(a) Yin, J.; Buchwald, S. L.
J. Am. Chem. Soc. 2002, 124, 6043. (b) Huang, X.; Anderson, K. W.;
Zim, D.; Jiang, L.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc.
2003, 125, 6653. (c) Ikawa, T.; Barder, T. E.; Biscoe, M. R.; Buchwald,
S. L. J. Am. Chem. Soc. 2007, 129, 13001.
(5) (a) Palucki, M.; Buchwald, S. L. J. Am. Chem. Soc. 1997, 119, 11108.
(b) Fox, J. M.; Huang, X.; Chieffi, A.; Buchwald, S. L. J. Am. Chem.
Soc. 2000, 122, 1360. (c) Hamada, T.; Chieffi, A.; Ahman, J.;
Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 1261. (d) Nguyen,
H. N.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2003, 125,
11818.
(10) Karnachi, A. A.; Bateman, S. D. (Novartis-AG) Pharmaceutical
Composition Comprising Lumiracoxib. WO 03/020261 A1, March 13,
2003.
(11) Acemoglu, M.; Allmendinger, T.; Calienni, J.; Cercus, J.; Loiseleur,
O.; Sedelmier, G. H.; Xu, D. Tetrahedron 2004, 60, 11571.
(6) Hennessy, E. J.; Buchwald, S. L. Org. Lett. 2002, 4, 269.
9
10.1021/ja803179s CCC: $40.75
2008 American Chemical Society
J. AM. CHEM. SOC. 2008, 130, 9613–9620 9613